We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Ameren
AEE
$30.3B
| $39.4M | 0.07% |
512,447
+23,392
| +5% | +$1.78M |
|
277
Quest Diagnostics
DGX
$25.7B
| $39.3M | 0.07% |
367,821
+13,437
| +4% | +$1.4M |
|
278
Dollar Tree
DLTR
$24.4B
| $39M | 0.07% |
414,693
+12,757
| +3% | +$1.34M |
|
279
Hewlett Packard
HPE
$63.4B
| $38.9M | 0.07% |
2,453,989
+55,319
| +2% | +$884K |
|
280
Essex Property Trust
ESS
$18.3B
| $38.8M | 0.07% |
129,102
+8,618
| +7% | +$2.72M |
|
281
Kraft Heinz
KHC
$30.7B
| $38.5M | 0.06% |
1,196,756
+40,819
| +4% | +$1.24M |
|
282
Fortive
FTV
$17.9B
| $38.4M | 0.06% |
796,638
+2,035
| +0.3% | +$91.9K |
|
283
Ventas
VTR
$48B
| $38.1M | 0.06% |
659,754
+26,743
| +4% | +$1.68M |
|
284
CDW
CDW
$18.9B
| $38.1M | 0.06% |
266,668
+16,159
| +6% | +$2.14M |
|
285
Corteva
CTVA
$52.6B
| $38M | 0.06% |
1,284,185
+21,072
| +2% | +$558K |
|
286
Align Technology
ALGN
$12.1B
| $37.4M | 0.06% |
134,180
+3,374
| +3% | +$841K |
|
287
Aptiv
APTV
$12B
| $37.3M | 0.06% |
393,120
+22,168
| +6% | +$2.03M |
|
288
American Water Works
AWK
$26.7B
| $37.1M | 0.06% |
302,105
+8,836
| +3% | +$1.07M |
|
289
Synchrony
SYF
$24.7B
| $37M | 0.06% |
1,027,771
+49,385
| +5% | +$1.77M |
|
290
West Pharmaceutical
WST
$24B
| $36.8M | 0.06% |
244,854
-1,020
| -0.4% | -$149K |
|
291
M&T Bank
MTB
$35.7B
| $36.8M | 0.06% |
216,764
+1,069
| +0.5% | +$173K |
|
292
Labcorp
LH
$25B
| $36.7M | 0.06% |
252,415
+10,883
| +5% | +$1.57M |
|
293
Boston Properties
BXP
$11.2B
| $36.4M | 0.06% |
263,845
+7,835
| +3% | +$1.06M |
|
294
Teleflex
TFX
$6.05B
| $36.2M | 0.06% |
96,165
+6,369
| +7% | +$2.19M |
|
295
Keysight
KEYS
$54.5B
| $35.9M | 0.06% |
349,723
-19,554
| -5% | -$2M |
|
296
Copart
CPRT
$27B
| $35.8M | 0.06% |
1,573,084
+67,824
| +5% | +$1.45M |
|
297
Alexandria Real Estate Equities
ARE
$8.97B
| $35.8M | 0.06% |
221,334
+18,920
| +9% | +$2.98M |
|
298
Healthpeak Properties
DOC
$15.1B
| $35.6M | 0.06% |
1,032,849
+75,495
| +8% | +$2.64M |
|
299
Corning
GLW
$119B
| $35.1M | 0.06% |
1,205,304
+20,757
| +2% | +$602K |
|
300
Halliburton
HAL
$26.9B
| $35M | 0.06% |
1,430,845
+70,357
| +5% | +$1.48M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.